Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Elife|November 6, 2023
Dynamic analysis of circulating tumor DNA to predict the prognosis and monitor the treatment response of patients with metastatic triple-negative breast cancer: A prospective studyYajing Chi, Mu Su, Dongdong Zhou, et al.
Medicine|August 7, 2016
Impact on long-term survival of the number of lymph nodes resected in patients with pT1N0 gastric cancer after R0 resection: A multicenter study in ChinaJiuda Zhao, Feng Du, Yu Zhang, et al.
Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society for Environmental Toxicology and Cancer|June 13, 2017
Impact of High Altitude on Clinicopathological Features and Prognosis after R0 Resection for Gastric Cancer: A Population-Based Multicenter StudyJiuda Zhao, Feng Du, Yu Zhang, et al.
Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society for Environmental Toxicology and Cancer|December 29, 2017
Relationship between Topoisomerase II Alpha Overexpression and Prognosis in Chinese Gastric Cancer PatientsFangchao Zheng, Jiuda Zhao, Feng Du, et al.
Annals of Translational Medicine|January 20, 2023
Survival analysis and nomogram for early-stage occult breast cancer with positive lymph nodes based on the SEER databaseXiaochu Man, Han Xu, Hongxia Wang, et al.
Cancer Control : Journal of the Moffitt Cancer Center|January 19, 2026
Real-World Outcomes With Inetetamab-Based Regimens for HER2-Positive Metastatic Breast Cancer: A Multicenter Retrospective Analysis in ChinaFangchao Zheng, Jiale Zhang, Dongdong Zhou, et al.
Breast Cancer Research and Treatment|October 14, 2021
Updated efficacy of adjuvant epirubicin plus cyclophosphamide followed by taxanes versus carboplatin plus taxanes in early triple-negative breast cancer in phase 2 trial: 8.1-year median follow-upFangchao Zheng, Feng Du, Wenmiao Wang, et al.
Clinical and Translational Medicine|May 13, 2024
Efficacy and safety of pyrotinib combined with albumin-bound paclitaxel as first-line treatment for HER2-positive metastatic breast cancer in patients previously treated with adjuvant and/or neoadjuvant trastuzumab therapy: The stage 1 results of a single-arm, phase 2 prospective clinical trialXiaochu Man, Jie Huang, Shujuan Sun, et al.
Pageof 3